Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 1104 | 1093 | 1329 | 1591 | 2795 |
Fund Return | 5.66% | 10.39% | 9.35% | 9.95% | 9.73% | 10.83% |
Place in category | 447 | 485 | 272 | 99 | 126 | 96 |
% in Category | 40 | 45 | 30 | 23 | 29 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust F Acc | 750.99K | 10.67 | 13.38 | 15.24 | ||
Legal General US Index Trust F Dist | 20.11K | 10.62 | 13.37 | 15.23 | ||
Legal General US Index Trust C Acc | 3.51B | 7.11 | 14.19 | 15.31 | ||
Legal General US Index Trust C Dist | 932.95M | 7.07 | 14.19 | 15.30 | ||
Legal General US Index Trust I Acc | 1.38B | 7.04 | 14.13 | 15.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.85B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.46B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 115.51M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.54B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Acc | 255.64K | 8.14 | 10.01 | 11.74 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.26 | 732.80 | +1.09% | |
UnitedHealth | US91324P1021 | 6.04 | 495.42 | +0.32% | |
J&J | US4781601046 | 5.07 | 146.13 | -0.47% | |
Novo Nordisk B | DK0062498333 | 4.89 | 886.6 | +2.28% | |
Merck&Co | US58933Y1055 | 4.23 | 131.19 | +0.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Sell | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review